RxDoctor Payments Data

Michael Younes

Foot & Ankle Surgery · Lancaster, PANPI 1760469688

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $21,800 of the $34,110 with a category attached, or 63.9%. International Life Sciences accounts for 61.8% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $18,168 and has fallen 89.7% since, to $1,878 in 2025. Among foot & ankle surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,110in general payments, 2019–2025

Across 110 payments — averaging $310.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Life Sciences$21K
  • Novus Surgical Solutions LLC$3K
  • Arthrex$3K
  • Novus Surgical Consultants$3K
  • Stryker$2K
  • Organogenesis Inc.$321
  • plus $1K from 19 others

What the payments were for

  • Consulting fees$21,80064%
  • Travel & lodging$5,85217%
  • Food & beverage$5,25815%
  • Education$1,2004%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
International Life Sciences13$21,085
Novus Surgical Solutions LLC7$3,434
Arthrex11$3,074
Novus Surgical Consultants18$2,517
Stryker(2 entities)25$2,325
Organogenesis Inc.7$321
Zimmer Biomet2$186
Averitas Pharma Inc.3$183
GRT US Holding, Inc.3$168
Abbott1$142
Trimed, Inc.1$114
Smith+Nephew4$97
Merck1$94
Exactech, Inc.1$80
Aroa Biosurgery Incorporated1$63
Novastep Inc.2$53
Heron Therapeutics, Inc.1$33
Kowa Pharmaceuticals America, Inc.2$32
Vertex1$23
Alfasigma USA, Inc.1$16
Bioventus LLC1$15
Treace Medical Concepts, Inc.1$15
Paragon 28, Inc.1$15
Pfizer1$14
Zyla Life Sciences, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,110 in reported general payments places this provider in the 90th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$189,623
Medicare patients
375
Services billed
1,948

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin92$1,010
Ketoconazole14$434
Cephalexin19$394
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$35
Meloxicam11$33

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →